Latest filing published 01 Sept 2016 for RIGEL PHARMACEUTICALS INC, €19k.
Insider track record
No signal scores available.
Donald G. Payan: trading record in brief
Donald G. Payan discloses dealings in Rigel Pharmaceuticals Inc to SEC (Form 4). In total, 11 filings cover trades dated from 2 January 2009 to 30 August 2016.
Every open-market trade on record is a sale: 9 sales worth €351k. Other entries cover 2 option exercises. Since January 2016: no purchases and 1 sale on the market.
Most recently, on 1 September 2016, the filings show an open-market sale worth €19k in Rigel Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Donald G. Payan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,303 shares@ US$4.00100.0% of flowCommon StockSEC:0001179110-16-029221:0
- 41,666 shares@ US$2.14Common StockSEC:0001179110-15-009742:0
- 41,666 shares@ US$3.68Common StockSEC:0001179110-15-009742:1
- 10,000 shares@ US$3.75Common StockSEC:0001179110-15-006005:0
- 20,000 shares@ US$2.56Common StockSEC:0001179110-14-013776:0
- 20,000 shares@ US$3.71Common StockSEC:0001179110-14-003778:0
- 100 shares@ US$8.75Common StockSEC:0001179110-12-010606:0
- 100 shares@ US$8.72Common StockSEC:0001179110-12-010606:1
- 9,700 shares@ US$8.70Common StockSEC:0001179110-12-010606:2
- 100 shares@ US$8.71Common StockSEC:0001179110-12-010606:3
- 3,334 shares@ US$1.80Common StockSEC:0001179110-09-000703:0
11 of 11 declarations
